Some past studies have found that FTO promotes the growth of lung cancer cells (Li J et al., 2019), but in this study, the expression of FTO in the low-risk group was higher than that in the high-risk group, which suggests that the m6A regulatory gene may have changed in platinum-resistant patients with LUAD. The gene discussed is FTO; the disease is lung carcinoma.